Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$14.2 - $23.78 $121,381 - $203,271
-8,548 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$18.16 - $25.21 $155,231 - $215,495
8,548 New
8,548 $211,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.18B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.